UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Placental inflammation in pre‐eclampsia by Nod‐like receptor protein (NLRP)3 inflammasome activation in trophoblasts

Clinical and experimental immunology, 2018-07, Vol.193 (1), p.84-94

2018

Volltextzugriff (PDF)

NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer

Gynecologic oncology, 2024-09, Vol.188, p.103-110

2024

Volltextzugriff (PDF)

Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and KEAP1 in Preeclampsia with and without Fetal Growth Restriction

International journal of molecular sciences, 2022-02, Vol.23 (4), p.1966

2022

Volltextzugriff (PDF)

Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial

Annals of oncology, 2024-08, Vol.35 (8), p.728-738

2024

Volltextzugriff (PDF)

Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas

British journal of cancer, 2014-01, Vol.110 (1), p.107-114

2014

Volltextzugriff (PDF)

Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas

Clinical radiology, 2015-05, Vol.70 (5), p.487-494

2015

Volltextzugriff (PDF)

Asparaginase‐like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study

BJOG : an international journal of obstetrics and gynaecology, 2018-12, Vol.125 (13), p.1695-1703

2018

Volltextzugriff (PDF)

Matrix Metalloproteinase 1 in Pre-eclampsia and Fetal Growth Restriction: Reduced Gene Expression in Decidual Tissue and Protein Expression in Extravillous Trophoblasts

Placenta (Eastbourne), 2010-07, Vol.31 (7), p.615-620

2010

Volltextzugriff (PDF)

Increased endoplasmic reticulum stress in decidual tissue from pregnancies complicated by fetal growth restriction with and without pre-eclampsia

Placenta (Eastbourne), 2011-11, Vol.32 (11), p.823-829

2011

Volltextzugriff (PDF)

Ascitic complement system in ovarian cancer

British journal of cancer, 2005-03, Vol.92 (5), p.895-905

2005

Volltextzugriff (PDF)

Medical abortion at 63 to 90 days of gestation

Obstetrics and gynecology (New York. 1953), 2010-05, Vol.115 (5), p.962-968

2010

Volltextzugriff (PDF)

STOX2 but not STOX1 is differentially expressed in decidua from pre-eclamptic women: data from the Second Nord-Trøndelag Health Study

Molecular human reproduction, 2010-12, Vol.16 (12), p.960-968

2010

Volltextzugriff (PDF)

Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells

British journal of cancer, 2002-11, Vol.87 (10), p.1119-1127

2002

Volltextzugriff (PDF)

EP889 Improved cytoreduction of ovarian cancer using CD24-targeted fluorescence image-guided surgery in a preclinical murine model

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A176-A176

2019

Volltextzugriff (PDF)

Minimal Residual Disease in Ovarian Cancer as a Target for Complement‐Mediated mAb Immunotherapy

Scandinavian journal of immunology, 2006-05, Vol.63 (5), p.355-364

2006

Volltextzugriff (PDF)

P27.06: Contrast‐enhanced transperineal ultrasound in mid‐compartment prolapse evaluation

Ultrasound in obstetrics & gynecology, 2016-09, Vol.48 (S1), p.257-257

2016

Volltextzugriff (PDF)

EP858 What you should know about tumor reductive surgery in advanced ovarian cancer – clinical recommendations from a patient perspective

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A467-A467

2019

Volltextzugriff (PDF)

26 Pregnancy and severe thrombophilia: 35 pregnancies in hereditary antithrombin deficient women in Norway

Thrombosis research, 2007, Vol.119, p.S104-S104

2007

Volltextzugriff (PDF)

The DNA methylome of cervical cells can predict the presence of ovarian cancer

Nature communications, 2022-02, Vol.13 (1), p.448-12, Article 448

2022

Volltextzugriff (PDF)

LBA28 A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial

Annals of oncology, 2020-09, Vol.31, p.S1160-S1160

2020

Volltextzugriff (PDF)

The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples

Nature communications, 2022-02, Vol.13 (1), p.449-449, Article 449

2022

Volltextzugriff (PDF)

Placental Expression of Glycophosphatidylinositol (GPI)‐anchored Proteins in Paroxysmal Nocturnal Haemoglobinuria

Scandinavian journal of immunology, 2006-08, Vol.64 (2), p.140-144

2006

Volltextzugriff (PDF)

A phase 1 study to evaluate the safety and tolerability of bevacizumab-niraparib combination therapy and determine the recommended phase 2 dose (RP2D) in women with platinum-sensitive epithelial ovarian cancer (ENGOT-OV24/AVANOVA1)

Annals of oncology, 2017-09, Vol.28, p.v339-v339

2017

Volltextzugriff (PDF)

Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line

Cancer Immunology, Immunotherapy, 1996-03, Vol.42 (3), p.185-192

1996

Volltextzugriff (PDF)

1 – 25 von 225

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(208)
Mit Volltextzugriff
(192)

Publikationsform

Artikel
(214)
Tagungsberichte
(11)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(155)
Life Sciences & Biomedicine
(140)
Humans
(120)
Female
(95)
Medicin Och Hälsovetenskap
(56)
Adult
(44)
Biological And Medical Sciences
(43)
Middle Aged
(41)
Oncology
(41)
Risk Factors
(37)
Male
(35)
Aged
(32)
Pregnancy
(31)
Tumors
(30)
Medical Sciences
(29)
Cancer
(27)
Ovarian Cancer
(22)
Case-Control Studies
(19)
Fundamental And Applied Biological Sciences. Psychology
(16)
Norway
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Placental inflammation in pre‐eclampsia by Nod‐like receptor protein (NLRP)3 inflammasome activation in trophoblasts

NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer

Divergent Regulation of Decidual Oxidative-Stress Response by NRF2 and KEAP1 in Preeclampsia with and without Fetal Growth Restriction

Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial

Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas

Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas

Asparaginase‐like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study

Matrix Metalloproteinase 1 in Pre-eclampsia and Fetal Growth Restriction: Reduced Gene Expression in Decidual Tissue and Protein Expression in Extravillous Trophoblasts

Increased endoplasmic reticulum stress in decidual tissue from pregnancies complicated by fetal growth restriction with and without pre-eclampsia

Ascitic complement system in ovarian cancer

Medical abortion at 63 to 90 days of gestation

STOX2 but not STOX1 is differentially expressed in decidua from pre-eclamptic women: data from the Second Nord-Trøndelag Health Study

Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells

EP889 Improved cytoreduction of ovarian cancer using CD24-targeted fluorescence image-guided surgery in a preclinical murine model

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

Minimal Residual Disease in Ovarian Cancer as a Target for Complement‐Mediated mAb Immunotherapy

P27.06: Contrast‐enhanced transperineal ultrasound in mid‐compartment prolapse evaluation

EP858 What you should know about tumor reductive surgery in advanced ovarian cancer – clinical recommendations from a patient perspective

26 Pregnancy and severe thrombophilia: 35 pregnancies in hereditary antithrombin deficient women in Norway

The DNA methylome of cervical cells can predict the presence of ovarian cancer

LBA28 A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial

The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples

Placental Expression of Glycophosphatidylinositol (GPI)‐anchored Proteins in Paroxysmal Nocturnal Haemoglobinuria

A phase 1 study to evaluate the safety and tolerability of bevacizumab-niraparib combination therapy and determine the recommended phase 2 dose (RP2D) in women with platinum-sensitive epithelial ovarian cancer (ENGOT-OV24/AVANOVA1)

Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line

Suchergebnisse filtern